Pancreatic Islet-Specific Expression of an Insulin-Like Growth Factor-I Transgene Compensates Islet Cell Growth in Growth Hormone Receptor Gene-Deficient Mice
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Both GH and IGF-I stimulate islet cell growth, inhibit cell apoptosis, and regulate insulin biosynthesis and secretion. GH receptor gene deficiency (GHR(-/-)) caused diminished pancreatic islet cell mass and serum insulin level and elevated insulin sensitivity. Because IGF-I gene expression was nearly abolished in these mice, we sought to determine whether that had caused the islet defects. To restore IGF-I level, we have generated transgenic mice that express rat IGF-I cDNA under the direction of rat insulin promoter 1 (RIP-IGF). Using RNase protection assay and immunohistochemistry, the IGF-I transgene expression was revealed specifically in pancreatic islets of the RIP-IGF mice, which exhibited normal growth and development and possess no abnormalities in glucose homeostasis, insulin production, and islet cell mass. GHR(-/-) mice exhibited 50% reduction in the ratio of islet cell mass to body weight and increased insulin sensitivity but impaired glucose tolerance. Compared with GHR(-/-) alone, IGF-I overexpression on a GHR(-/-) background caused no change in the diminished blood glucose and serum insulin levels, pancreatic insulin contents, and insulin tolerance but improved glucose tolerance and insulin secretion. Remarkably, islet-specific overexpression of IGF-I gene in GHR(-/-) mice restored islet cell mass, at least partially through cell hypertrophy. Interestingly, double-transgenic male mice demonstrated a transient rescue in growth rates vs. GHR(-/-) alone, at 2-3 months of age. Our results suggest that IGF-I deficiency is part of the underlying mechanism of diminished islet growth in GHR(-/-) mice and are consistent with the notion that IGF-I mediates GH-induced islet cell growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Five stages of evolving beta-cell dysfunction during progression to diabetes
Weir, G. C., & Bonner-Weir, S. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s16 · Cited by 1,126
beta-cell turnover: its assessment and implications.
Bonner-Weir, S. (2001) · Diabetes · doi:10.2337/diabetes.50.2007.s20 · Cited by 230
Parsons, J. A., Bartke, A., & Sorenson, R. L. (1995) · Endocrinology · doi:10.1210/en.136.5.2013 · Cited by 152
Friedrichsen, B. N., Richter, H. E., Hansen, J. A., Rhodes, C. J., Nielsen, J. H., Billestrup, N., & Møldrup, A. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0356 · Cited by 93
Research works printed but not linked: 43
- Le Roith, 2001, The somatomedin hypothesis: 2001, Endocr Rev, 22, 53, 10.1210/edrv.22.1.0419 · DOI · Paper page
- Nielsen, 1990, Expression of the growth hormone receptor gene in insulin producing cells, Biomed Biochim Acta, 49, 1151
- Fehmann, 1996, Functional active receptors for insulin-like growth factors-I (IGF-I) and IGF-II on insulin-, glucagon-, and somatostatin-producing cells, Metabolism, 45, 759, 10.1016/S0026-0495(96)90143-2 · DOI
- Nielsen, 1989, Growth hormone is a growth factor for the differentiated pancreatic β-cell, Mol Endocrinol, 3, 165, 10.1210/mend-3-1-165 · DOI · Paper page
- Hugl, 1998, Insulin-like growth factor I (IGF-I)-stimulated pancreatic β-cell growth is glucose-dependent. Synergistic activation of insulin receptor substrate-mediated signal transduction pathways by glucose and IGF-I in INS-1 cells, J Biol Chem, 273, 17771, 10.1074/jbc.273.28.17771 · DOI · Paper page
- Harrison, 1998, Growth factor protection against cytokine-induced apoptosis in neonatal rat islets of Langerhans: role of Fas, FEBS Lett, 435, 207, 10.1016/S0014-5793(98)01051-5 · DOI
- Dominici, 2000, Compensatory alterations of insulin signal transduction in liver of growth hormone receptor knockout mice, J Endocrinol, 166, 579, 10.1677/joe.0.1660579 · DOI · Paper page
- Liu, 2004, Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice, Am J Physiol Endocrinol Metab, 287, E405, 10.1152/ajpendo.00423.2003 · DOI · Paper page
- Zhou, 1997, A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse), Proc Natl Acad Sci USA, 94, 13215, 10.1073/pnas.94.24.13215 · DOI · Paper page
- Devedjian, 2000, Transgenic mice overexpressing insulin-like growth factor-II in β cells develop type 2 diabetes, J Clin Invest, 105, 731, 10.1172/JCI5656 · DOI · Paper page
- Valera, 1994, Expression of GLUT-2 antisense RNA in β cells of transgenic mice leads to diabetes, J Biol Chem, 269, 28543, 10.1016/S0021-9258(19)61937-X · DOI · Paper page
- Neuenschwander, 1996, Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model, J Clin Invest, 97, 2225, 10.1172/JCI118663 · DOI · Paper page
- Chandrashekar, 1999, Pituitary and testicular function in growth hormone receptor gene knockout mice, Endocrinology, 140, 1082, 10.1210/endo.140.3.6557 · doi:10.1210/endo.140.3.6557 · Paper page
- Miao, 2001, Osteomalacia in Hyp mice is associated with abnormal Phex expression and with altered bone matrix protein expression and deposition, Endocrinology, 142, 926, 10.1210/endo.142.2.7976 · DOI · Paper page
- Hsu, 1981, Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures, J Histochem Cytochem, 29, 577, 10.1177/29.4.6166661 · DOI · Paper page
- Chomczynski, 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal Biochem, 162, 156, 10.1016/0003-2697(87)90021-2 · DOI · Paper page
- Vasavada, 1996, Overexpression of parathyroid hormone-related protein in the pancreatic islets of transgenic mice causes islet hyperplasia, hyperinsulinemia, and hypoglycemia, J Biol Chem, 271, 1200, 10.1074/jbc.271.2.1200 · DOI · Paper page
- Liu, 1998, Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice, Mol Endocrinol, 12, 1452, 10.1210/mend.12.9.0162 · DOI · Paper page
- Rosenau, 2002, Development of a chemiluminescence-based ribonuclease protection assay, Biotechniques, 33, 1354, 10.2144/02336pf02 · DOI
- Kulkarni, 1999, Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes, Cell, 96, 329, 10.1016/S0092-8674(00)80546-2 · DOI · Paper page
- George, 2002, β-Cell expression of IGF-I leads to recovery from type 1 diabetes, J Clin Invest, 109, 1153, 10.1172/JCI0212969 · DOI · Paper page
- Rhodes, 2000, IGF-I and GH post-receptor signaling mechanisms for pancreatic β-cell replication, J Mol Endocrinol, 24, 303, 10.1677/jme.0.0240303 · DOI · Paper page
- Dominici, 2002, Growth hormone-induced alterations in the insulin-signaling system, Exp Biol Med (Maywood), 227, 149, 10.1177/153537020222700301 · DOI
- Okuda, 2001, Acute effects of growth hormone on metabolism of pancreatic hormones, glucose and ketone bodies, Diabetes Res Clin Pract, 53, 1, 10.1016/S0168-8227(01)00232-7 · DOI
- Nielsen, 2001, Regulation of β-cell mass by hormones and growth factors, Diabetes, 50, S25, 10.2337/diabetes.50.2007.S25 · DOI · Paper page
- Rabinovitch, 1983, Growth hormone stimulates islet B-cell replication in neonatal rat pancreatic monolayer cultures, Diabetes, 32, 307, 10.2337/diab.32.4.307 · DOI
- Galsgaard, 1996, Identification of a growth hormone-responsive STAT5-binding element in the rat insulin 1 gene, Mol Endocrinol, 10, 652
- Galsgaard, 1999, Regulation of prolactin receptor (PRLR) gene expression in insulin-producing cells. Prolactin and growth hormone activate one of the rat prlr gene promoters via STAT5a and STAT5b, J Biol Chem, 274, 18686, 10.1074/jbc.274.26.18686 · DOI · Paper page
- Sims, 2000, Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5, J Clin Invest, 106, 1095, 10.1172/JCI10753 · DOI · Paper page
- Bachelot, 2002, Growth hormone is required for ovarian follicular growth, Endocrinology, 143, 4104, 10.1210/en.2002-220087 · DOI · Paper page
- Swenne, 1989, Growth hormone regulation of DNA replication, but not insulin production, is partly mediated by somatomedin-C/insulin-like growth factor I in isolated pancreatic islets from adult rats, Diabetologia, 32, 191, 10.1007/BF00265093 · DOI
- Hill, 1991, Growth factor control of pancreatic B cell hyperplasia, Baillieres Clin Endocrinol Metab, 5, 689, 10.1016/S0950-351X(10)80010-2 · DOI
- Maake, 1993, Immunohistochemical localization of insulin-like growth factor 1 and 2 in the endocrine pancreas of rat, dog, and man, and their coexistence with classical islet hormones, Cell Tissue Res, 273, 249, 10.1007/BF00312826 · DOI
- Portela-Gomes, 2000, Insulin-like growth factor II in human fetal pancreas and its co-localization with the major islet hormones: comparison with adult pancreas, J Endocrinol, 165, 245, 10.1677/joe.0.1650245 · DOI
- Hill, 2000, Increased and persistent circulating insulin-like growth factor II in neonatal transgenic mice suppresses developmental apoptosis in the pancreatic islets, Endocrinology, 141, 1151, 10.1210/endo.141.3.7354 · DOI
- Xuan, 2002, Defective insulin secretion in pancreatic β-cells lacking type 1 IGF receptor, J Clin Invest, 110, 1011, 10.1172/JCI0215276 · doi:10.1172/jci0215276 · Paper page
- Kulkarni, 2002, β-Cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter β-cell mass, Nat Genet, 31, 111, 10.1038/ng872 · DOI · Paper page
- Yakar, 2001, Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity, Diabetes, 50, 1110, 10.2337/diabetes.50.5.1110 · DOI · Paper page
- Zhao, 2004, Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice, J Clin Invest, 113, 96, 10.1172/JCI200417763 · DOI
- Yu, 2003, Liver-specific IGF-I gene deficient mice exhibit accelerated diabetes in response to streptozotocin, associated with early onset of insulin resistance, Mol Cell Endocrinol, 204, 31, 10.1016/S0303-7207(03)00145-X · DOI
- Lu, 2004, Pancreatic specific inactivation of IGF-I gene causes enlarged pancreatic islets and significant resistance to diabetes, Diabetes, 53, 3131, 10.2337/diabetes.53.12.3131 · DOI · Paper page
- Billestrup, 1991, The stimulatory effect of growth hormone, prolactin, and placental lactogen on β-cell proliferation is not mediated by insulin-like growth factor-I, Endocrinology, 129, 883, 10.1210/endo-129-2-883 · DOI · Paper page
- Cousin, 1999, Stimulation of pancreatic β-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling, Biochem J, 344, 649, 10.1042/bj3440649 · doi:10.1042/bj3440649
Cited by
Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1
LeRoith, D., & Yakar, S. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0427 · Cited by 344
“In GH-receptor-knockout mice, if IGF1 was expressed under the control of the insulin promoter specifically in β-cells, IGF1 restored islet cell mass and, therefore, led to increased insulin content in the β-cells and improved insulin secretion and glucose tolerance”
BackgroundThe intricate role of growth hormone in metabolism
Vijayakumar, A., Yakar, S., & LeRoith, D. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00032 · Cited by 179
Insulin-like growth factor I, growth hormone and insulin in white adipose tissue
Blüher, S., Kratzsch, J., & Kiess, W. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.07.011 · Cited by 114
Luque, R. M., Lin, Q., Córdoba-Chacón, J., Subbaiah, P. V., Buch, T., Waisman, A., Vankelecom, H., & Kineman, R. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015767 · Cited by 73
Effects of GABAB receptor agonists and antagonists on glycemia regulation in mice
Bonaventura, M. M., Crivello, M., Ferreira, M. L., Repetto, M., Cymeryng, C., Libertun, C., & Lux-Lantos, V. A. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.12.013 · Cited by 19
Metadata
- Authors
- Guo, Y., Lu, Y., Houle, D., Robertson, K., Tang, Z., Kopchick, J. J., Liu, Y. L., & Liu, J.-L.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2005-06-01
- Volume
- 146
- Issue
- 6
- Pages
- 2602-2609
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2061634582
- Cited by
- 60
- References
- 4
- FWCI
- 4.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pancreatic Islet-Specific Expression of an Insulin-Like Growth Factor-I Transgene Compensates Islet Cell Growth in Growth Hormone Receptor Gene-Deficient Mice. https://app.cochat.ai/papers/10.1210/en.2004-1203
- The paper
- Guo, Y., Lu, Y., Houle, D., Robertson, K., Tang, Z., Kopchick, J. J., Liu, Y. L., & Liu, J.-L. (2005). Pancreatic Islet-Specific Expression of an Insulin-Like Growth Factor-I Transgene Compensates Islet Cell Growth in Growth Hormone Receptor Gene-Deficient Mice. Endocrinology. https://doi.org/10.1210/en.2004-1203
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.